Literature DB >> 28867526

From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

Carole Henry1, Anna-Karin E Palm2, Florian Krammer3, Patrick C Wilson4.   

Abstract

Antibody responses are essential for protection against influenza virus infection. Humans are exposed to a multitude of influenza viruses throughout their lifetime and it is clear that immune history influences the magnitude and quality of the antibody response. The 'original antigenic sin' concept refers to the impact of the first influenza virus variant encounter on lifelong immunity. Although this model has been challenged since its discovery, past exposure, and likely one's first exposure, clearly affects the epitopes targeted in subsequent responses. Understanding how previous exposure to influenza virus shapes antibody responses to vaccination and infection is critical, especially with the prospect of future pandemics and for the effective development of a universal influenza vaccine.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28867526      PMCID: PMC5748348          DOI: 10.1016/j.it.2017.08.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  93 in total

1.  The Quest for a Universal Flu Vaccine: Headless HA 2.0.

Authors:  Florian Krammer
Journal:  Cell Host Microbe       Date:  2015-10-14       Impact factor: 21.023

Review 2.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

3.  A common solution to group 2 influenza virus neutralization.

Authors:  Robert H E Friesen; Peter S Lee; Esther J M Stoop; Ryan M B Hoffman; Damian C Ekiert; Gira Bhabha; Wenli Yu; Jarek Juraszek; Wouter Koudstaal; Mandy Jongeneelen; Hans J W M Korse; Carla Ophorst; Els C M Brinkman-van der Linden; Mark Throsby; Mark J Kwakkenbos; Arjen Q Bakker; Tim Beaumont; Hergen Spits; Ted Kwaks; Ronald Vogels; Andrew B Ward; Jaap Goudsmit; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-11       Impact factor: 11.205

4.  Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.

Authors:  Gui-Mei Li; Christopher Chiu; Jens Wrammert; Megan McCausland; Sarah F Andrews; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Xinyan Qu; Srilatha Edupuganti; Mark Mulligan; Suman R Das; Jonathan W Yewdell; Aneesh K Mehta; Patrick C Wilson; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

5.  Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.

Authors:  M Gordon Joyce; Adam K Wheatley; Paul V Thomas; Gwo-Yu Chuang; Cinque Soto; Robert T Bailer; Aliaksandr Druz; Ivelin S Georgiev; Rebecca A Gillespie; Masaru Kanekiyo; Wing-Pui Kong; Kwanyee Leung; Sandeep N Narpala; Madhu S Prabhakaran; Eun Sung Yang; Baoshan Zhang; Yi Zhang; Mangaiarkarasi Asokan; Jeffrey C Boyington; Tatsiana Bylund; Sam Darko; Christopher R Lees; Amy Ransier; Chen-Hsiang Shen; Lingshu Wang; James R Whittle; Xueling Wu; Hadi M Yassine; Celia Santos; Yumiko Matsuoka; Yaroslav Tsybovsky; Ulrich Baxa; James C Mullikin; Kanta Subbarao; Daniel C Douek; Barney S Graham; Richard A Koup; Julie E Ledgerwood; Mario Roederer; Lawrence Shapiro; Peter D Kwong; John R Mascola; Adrian B McDermott
Journal:  Cell       Date:  2016-07-21       Impact factor: 41.582

6.  Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.

Authors:  Matthew S Miller; Thomas J Gardner; Florian Krammer; Lauren C Aguado; Domenico Tortorella; Christopher F Basler; Peter Palese
Journal:  Sci Transl Med       Date:  2013-08-14       Impact factor: 17.956

7.  Antibody landscapes after influenza virus infection or vaccination.

Authors:  J M Fonville; S H Wilks; S L James; A Fox; M Ventresca; M Aban; L Xue; T C Jones; N M H Le; Q T Pham; N D Tran; Y Wong; A Mosterin; L C Katzelnick; D Labonte; T T Le; G van der Net; E Skepner; C A Russell; T D Kaplan; G F Rimmelzwaan; N Masurel; J C de Jong; A Palache; W E P Beyer; Q M Le; T H Nguyen; H F L Wertheim; A C Hurt; A D M E Osterhaus; I G Barr; R A M Fouchier; P W Horby; D J Smith
Journal:  Science       Date:  2014-11-21       Impact factor: 47.728

8.  Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins.

Authors:  Raffael Nachbagauer; Angela Choi; Ariana Hirsh; Irina Margine; Sayaka Iida; Aldo Barrera; Marcela Ferres; Randy A Albrecht; Adolfo García-Sastre; Nicole M Bouvier; Kimihito Ito; Rafael A Medina; Peter Palese; Florian Krammer
Journal:  Nat Immunol       Date:  2017-02-13       Impact factor: 25.606

9.  Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus.

Authors:  F M DAVENPORT; A V HENNESSY; T FRANCIS
Journal:  J Exp Med       Date:  1953-12       Impact factor: 14.307

10.  Stalking influenza by vaccination with pre-fusion headless HA mini-stem.

Authors:  Sophie A Valkenburg; V Vamsee Aditya Mallajosyula; Olive T W Li; Alex W H Chin; George Carnell; Nigel Temperton; Raghavan Varadarajan; Leo L M Poon
Journal:  Sci Rep       Date:  2016-03-07       Impact factor: 4.379

View more
  81 in total

1.  Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance.

Authors:  Yao-Qing Chen; Linda Yu-Ling Lan; Min Huang; Carole Henry; Patrick C Wilson
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Influenza in obese travellers: increased risk and complications, decreased vaccine effectiveness.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  J Travel Med       Date:  2019-05-10       Impact factor: 8.490

3.  Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach.

Authors:  Weina Sun; Ericka Kirkpatrick; Megan Ermler; Raffael Nachbagauer; Felix Broecker; Florian Krammer; Peter Palese
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

Review 4.  What Is a Host? Attributes of Individual Susceptibility.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

Review 5.  Adjuvanted influenza vaccines.

Authors:  John S Tregoning; Ryan F Russell; Ekaterina Kinnear
Journal:  Hum Vaccin Immunother       Date:  2018-01-25       Impact factor: 3.452

6.  Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans.

Authors:  Haley L Dugan; Jenna J Guthmiller; Philip Arevalo; Min Huang; Yao-Qing Chen; Karlynn E Neu; Carole Henry; Nai-Ying Zheng; Linda Yu-Ling Lan; Micah E Tepora; Olivia Stovicek; Dalia Bitar; Anna-Karin E Palm; Christopher T Stamper; Siriruk Changrob; Henry A Utset; Lynda Coughlan; Florian Krammer; Sarah Cobey; Patrick C Wilson
Journal:  Sci Transl Med       Date:  2020-12-09       Impact factor: 17.956

Review 7.  Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs.

Authors:  Santosh Dhakal; Sabra L Klein
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

8.  Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study.

Authors:  Carole Henry; Anna-Karin E Palm; Henry A Utset; Min Huang; Irvin Y Ho; Nai-Ying Zheng; Theresa Fitzgerald; Karlynn E Neu; Yao-Qing Chen; Florian Krammer; John J Treanor; Andrea J Sant; David J Topham; Patrick C Wilson
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

9.  Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus.

Authors:  Brenda L Tesini; Preshetha Kanagaiah; Jiong Wang; Megan Hahn; Jessica L Halliley; Francisco A Chaves; Phuong Q T Nguyen; Aitor Nogales; Marta L DeDiego; Christopher S Anderson; Ali H Ellebedy; Shirin Strohmeier; Florian Krammer; Hongmei Yang; Sanjukta Bandyopadhyay; Rafi Ahmed; John J Treanor; Luis Martinez-Sobrido; Hana Golding; Surender Khurana; Martin S Zand; David J Topham; Mark Y Sangster
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

10.  Birth Cohort Effects in Influenza Surveillance Data: Evidence That First Influenza Infection Affects Later Influenza-Associated Illness.

Authors:  Alicia P Budd; Lauren Beacham; Catherine B Smith; Rebecca J Garten; Carrie Reed; Krista Kniss; Desiree Mustaquim; Farida B Ahmad; Charisse N Cummings; Shikha Garg; Min Z Levine; Alicia M Fry; Lynnette Brammer
Journal:  J Infect Dis       Date:  2019-07-31       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.